EXHIBIT 10.57 Acceleration of Vesting of Premium Priced Stock Options

Exhibit 10.57

Acceleration of Vesting of Premium Priced Stock Options

On April 25, 2004, the Organization and Compensation Committee of the Allergan, Inc. (the “Company”) Board of Directors approved an acceleration of the vesting of options issued under the Allergan, Inc. 2001 Premium Priced Stock Option Plan (the “Plan”) that are held by the Company’s current employees, including its executive officers, and certain former employees who received grants while employees of the Company prior to the Company’s June 2002 spin-off of Advanced Medical Optics, Inc. (“AMO”). As a result of the acceleration, the second tranche and third tranche